作者: RAYMOND L. VANDE WIELE , R. NURAN TURKSOY
关键词:
摘要: Thirty-five patients with various types of ovarian dysfunction have been treated Pergonal, a follicle-stimulating hormone extracted from menopausal urine and human chorionic gonadotropin (HCG). Treatment in each instance was started Pergonal (4.75–18.0 mg equivalents FSHNIH-Sl daily). When sufficient follicular maturation obtained, oviolation induced HCG (4000–5000 IU Five had primary failure none these responded to treatment. Ovulation one or more times all other patients. Twenty complained infertility, 14 conceived.